收藏切换
Potential mechanism of Sophora flavescens against acute myeloid leukemia
收藏切换
Qiyuan MAO1, Lanchun LIU2, Ruijuan CAI1, Surui YUAN1, Huiling ZHOU3, Yulin KUANG4, Daorui LI1, Hongsheng LIN1, *
World Clinical Drug | 2022, 43(5) : 514 - 522
Less
收藏切换
World Clinical Drug | 2022, 43(5): 514-522
• Article •
Potential mechanism of Sophora flavescens against acute myeloid leukemia
Full
Qiyuan MAO1, Lanchun LIU2, Ruijuan CAI1, Surui YUAN1, Huiling ZHOU3, Yulin KUANG4, Daorui LI1, Hongsheng LIN1, *
Affiliations
  • 1.Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
  • 2.Department of Cardiovascular, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
  • 3.Department of Oncology, Yueyang Hospital Integrated of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
  • 4.Graduate School, Hunan University of Chinese Medicine, Changsha 410208, Hunan Province, China
Published: 2022-05-10 doi: 10.13683/j.wph.2022.05.006
Outline
收藏切换
Objective

To explore the potential mechanism of active components of Sophora flavescens in acute myeloid leukemia (AML) based on network pharmacology.

Methods

We searched Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform, and the effective active components and corresponding targets of Sophora flavescens were screened. The AML action targets were obtained by GeneCards database, and the intersection targets of drugs and diseases were obtained. Cytoscape3.7.2 software was used to construct the interaction network diagram of drug effective active components, targets and diseases. The protein-protein interaction (PPI) network is constructed with the help of STRING database, analyzed with R software, and then the network diagram is drawn with Cytoscape3.7.2 software, gene ontology biological process (GO-BP) functional enrichment analysis and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis were performed on the intersection targets.

Results

A total of 45 active components of Sophora flavescens were screened and matched, including 99 targets, 1 549 AML related targets, 64 drug disease intersection targets and 22 active components. 62 PPI core genes were screened. GO-BP function enrichment analysis showed that the target was mainly involved in the degradation of ubiquitin protein ligase, the apoptosis process with cysteine endopeptidase activity, the binding of activating transcription factors, the binding of nuclear hormone receptors and other biological processes. KEGG pathway enrichment showed that Sophora flavescens was mainly involved in the formation of proteoglycan, phosphatidylinositol-3-kinase serine/Akt kinase, tumor necrosis factor and human tumor suppressor gene p53 in cancer. It also provided a certain reference for exploring the multi-channel and multi-target mechanism of Sophora flavescens in the treatment of AML.

Conclusion

Sophora flavescens has the characteristics of multi-component, multi-target and multi-channel in the treatment of AML, which also provides a certain reference for further exploring the therapeutic effect and related mechanism of traditional Chinese medicine on AML.

network pharmacology  /  Sophora flavescens  /  acute myeloid leukemia
毛启远, 刘兰椿, 蔡瑞娟, 原苏芮, 周慧灵, 匡昱林, 李道睿, 林洪生. 苦参对急性髓系白血病的潜在作用机制探究. 世界临床药物, 2022 , 43 (5) : 514 -522 . DOI: 10.13683/j.wph.2022.05.006
Qiyuan MAO, Lanchun LIU, Ruijuan CAI, Surui YUAN, Huiling ZHOU, Yulin KUANG, Daorui LI, Hongsheng LIN. Potential mechanism of Sophora flavescens against acute myeloid leukemia[J]. World Clinical Drug, 2022 , 43 (5) : 514 -522 . DOI: 10.13683/j.wph.2022.05.006
Year 2022 volume 43 Issue 5
10
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.05.006
  • Receive Date:2021-02-12
  • Online Date:2026-11-19
  • Published:2022-05-10
Article Data
Affiliations
History
  • Received:2021-02-12
  • Revised:2021-11-12
Funding
Affiliations
    1.Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
    2.Department of Cardiovascular, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
    3.Department of Oncology, Yueyang Hospital Integrated of Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
    4.Graduate School, Hunan University of Chinese Medicine, Changsha 410208, Hunan Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.05.006
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT